A green approach to dual-drug nanoformulations with targeting and synergistic effects for cancer therapy.

A green approach to dual-drug nanoformulations with targeting and synergistic effects for cancer therapy.
复制标题

一种双药纳米制剂的绿色方法,具有癌症治疗的靶向和协同作用。

DOI:
10.1080/10717544.2016.1228716
复制
发表时间:
2017-11
期刊:
影响因子:
6
通讯作者:
Hou Z
Hou Z
中科院分区:
医学2区
文献类型:
--
作者:
Wu S;Yang X;Lu Y;Fan Z;Li Y;Jiang Y;Hou Z

文献摘要

参考文献

被引文献

相似文献

探索高效的双药纳米杂化药物,特别是那些具有高载药量、特异性靶向性和长期稳定性的纳米杂化药物,在癌症治疗中具有非常重要的意义。在水相中进行pH驱动的共沉淀,得到了由10-羟基喜树碱(HCPT)纳米针与甲氨蝶呤(MTX)-壳聚糖偶联物的外层整合组成的双药物纳米制剂。纳米杂化材料在水中的高度稳定性和MTX成分提供的靶向特性协同作用于肿瘤组织的长期和持久的药物释放特性和细胞摄取的增加。细胞毒性实验表明,双药纳米针对HeLa细胞具有显著的杀伤作用,其联合指数为0.33 ± 0.07。在细胞内化后,这两种药物成分的释放在体内产生了良好的抗癌活性,并将不良副作用降至最低。无载体、双药物纳米制剂的绿色方法的设计使开发用于癌症诊断和治疗的新兴药物输送系统成为可能。
Exploration of efficient dual-drug nanohybrids, particularly those with high drug loading, specific targeting property, and long-termed stability, is of highly importance in cancer therapy. A pH-driven coprecipitation was performed in the aqueous phase to obtain a dual-drug nanoformulation, composed of 10-hydroxycamptothecine (HCPT) nanoneedles integrated with an exterior thin layer of the methotrexate (MTX)–chitosan conjugate. The high stability of nanohybrids in water and the targeting property provided by the MTX ingredient function synergistically to the prolonged and sustained drug release property in tumor tissues and the increased cellular uptake. The cytotoxicity test illustrates that dual-drug nanoneedles possess the remarkable killing ability to HeLa cells with the combination index at 0.33 ± 0.07. After cellular internalization, the release of both drug ingredients results in an excellent anticancer activity in vivo with the minimized adverse side effects. Design of a green approach to the carrier-free, dual-drug nanoformulations enables to develop emerging drug delivery systems for cancer diagnosis and treatment.
DOI: 10.1002/smll.200900621
发表时间: 2009-12
期刊: SMALL
影响因子: 13.3
作者:
Chen, Alex M.;Zhang, Min;Wei, Dongguang;Stueber, Dirk;Taratula, Oleh;Minko, Tamara;He, Huixin
通讯作者: He, Huixin
无载体 HCPT/DOX 纳米药物通过改善细胞药物积累协同增强对乳腺癌细胞的治疗效果
DOI: 10.1021/mp500744m
发表时间: 2015-07-01
影响因子: 4.9
作者:
Chen, Fei;Zhao, Yuanyuan;Liang, Xing-Jie
通讯作者: Liang, Xing-Jie
DOI: 10.1038/nnano.2012.84
发表时间: 2012-08-01
影响因子: 38.3
作者:
Holme, Margaret N.;Fedotenko, Illya A.;Zumbuehl, Andreas
通讯作者: Zumbuehl, Andreas
DOI: 10.1016/j.jconrel.2007.03.012
发表时间: 2007-07-13
影响因子: 10.8
作者:
Kocbek, Petra;Obermajer, Natasa;Kristl, Julijana
通讯作者: Kristl, Julijana
DOI: 10.1158/1078-0432.ccr-08-0515
发表时间: 2009-01-15
影响因子: 11.5
作者:
Batist, Gerald;Gelmon, Karen A.;Louie, Arthur C.
通讯作者: Louie, Arthur C.